April 2008 Oncology News International

Testing AI-powered tools globally across diverse patient groups may ensure that they are accurate and consistent for all patients.

Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.

Use of Deep-IO may help refine treatment precision and identify patients with advanced NSCLC who are likely to benefit from immune checkpoint inhibitors.

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

James B. Yu, MD, MHS, FASTRO, didn’t always envision himself as a radiation oncologist, but now works tirelessly to treat patients and advance research for genitourinary cancers.

In patients with small cell lung cancer, Lambert-Eaton myasthenic syndrome leads to muscle weakness and can be discovered with no-cost testing such as anti-VGCC antibody testing.